Skip to content

The UK, US and the Eurozone in the week ahead


With the US Federal Reserve suggesting there is more ammunition available to bolster the US economy, what has the final week of May got in store for the markets?

US: Will Fed unveil fresh ammo?

In a recent interview with 60 Minutes, Jerome Powell claimed that the Federal Reserve had plenty left in the tank, stating that ‘there’s a lot more we can do…we’re not out of ammunition by a long shot. No, there’s really no limit to what we can do with these lending programs that we have’.

Well, investors are maybe after a further example of what the central bank has in its arsenal. The Fed’s lending various programs for medium-sized businesses and state and local governments – announced across March and April – are all meant to be up and running by the end of May. Will Powell and co. reveal anything new to go alongside the previously announced measures?

Another potentially major market mover could be any news regarding vaccines. We’ve seen time and again investors get giddy at misleading headlines regarding a cure, only to have their optimism punctured by reality.

Last week was no different. Boston-based firm Moderna reported its experimental covid-19 vaccine mRNA-1273 had seen positive results from its first human trial, causing sky-high gains, especially for the Dow Jones. And then the Boston Globe cast doubts on the whole affair, highlighting that the trial only covered 8 people, and that Moderna failed to publish any data to back up its claims.

You can almost guarantee that, despite all this, the markets will hungrily eat up any new vaccine headlines, though it is hard to anticipate when and in what form such news will arrive.

As for the US-China situation, Trump hasn’t really let up in his attacks, accusing the World Health Organisation of a pro-China bias and an ‘alarming lack of independence’ from Beijing, going so far as to threaten to revoke the USA’s membership. Exactly the kind of attitude needed during a global pandemic.

Beyond those big picture issues, the week sees the CB consumer confidence data on Tuesday and the Richmond manufacturing index on Wednesday, before a second look at the Q1 GDP reading is joined by the durable goods orders figures and the weekly jobless claims on Thursday. Friday then sees the Fed-favourite core PCE price index reading, personal spending, Chicago PMI, and revised UoM consumer sentiment numbers.

UK: FTSE the mercy of wider market sentiment

In an excessively quiet week post-Bank Holiday, the UK economic calendar is almost empty, barring the CBI realised sales reading on Tuesday and the Gfk consumer confidence number on Friday.

That’ll likely leave the FTSE at the mercy of the wider market sentiment, especially that emanating from the US, unless there is something unforeseen, like an announcement from Rishi Sunak.

UK: Stocks to Watch

In terms of the corporate calendar, Britvic and Provident Financial update on Wednesday, with Daily Mail General Trust and IWG on Thursday.

Eurozone: Key Economic Dates

There’s a solid stream of Eurozone data this week, including German retail sales on Tuesday, the ECB financial stability review on Wednesday, the German and Spanish inflation figures on Thursday and the German import prices, French GDP and region-wide inflation readings on Friday.

  • Visit Spreadex website

This article is brought to you in association with Spreadex. All opinions expressed in this article are from the author and do not necessarily represent the opinions of The Armchair Trader. You can find out more about Spreadex products and services here, or find more articles from Connor Campbell here.

Looking for great investing ideas? Sign up to our free newsletter.

Join us on WhatsApp

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

CME Group
FP Markets
Back To Top